Janssen Pharmaceuticals, Inc.
Titusville, NJ, United States
4
Total Recalls
0
Class I Recalls
0
Ongoing Recalls
Recalls by Janssen Pharmaceuticals, Inc.
FDA Drug
Class II
Terminated
Ortho-Novum 1/35 (norethindrone/ethinyl estradiol) Tablets, 1 mg/0.035 mg, 28-Day Regimen per pouch (NDC 50458-176-28), 6 Veridate Tablet Dispensers and 6 refills per carton (NDC 50458-176-06), Rx onl
October 23, 2018
Janssen Pharmaceuticals, Inc.
1,777 cartons units
FDA Drug
Class II
Terminated
Ortho-Novum 7/7/7 (norethindrone/ethinyl/estradiol) Tablets, 0.5 mg/0.035 mg, 0.75 mg/0.035 mg, 1 mg/0.035, 28-Day Regimen per pouch, packaged in a) 6 Veridate Tablet Dispensers and 6 Refill pouches (
October 23, 2018
Janssen Pharmaceuticals, Inc.
a) 3,956 cartons; b) 1 carton units
FDA Drug
Class II
Terminated
Ortho-Cept (0.15 mg desogestrel and 0.03 mg ethinyl estradiol) tablets, 28- count blister (21 active tablets and 7 placebo tablets)/ 6 blister packs per carton. Rx only, Jointly Manufactured by: Janss
April 29, 2015
Janssen Pharmaceuticals, Inc.
16,861 cartons/6 blister units (28 tablets) each units
FDA Drug
Class II
Terminated
Risperdal CONSTA (risperiDONE), 25 mg Dose Pack, Rx Only, Single Use Only Janssen Pharmaceuticals Inc., Titusville, NJ 08560 NDC 50458-306-11
September 11, 2013
Janssen Pharmaceuticals, Inc.
70,495 kits units